HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.
about
Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agentsWound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancerTherapeutic modulators of STAT signalling for human diseasesPathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseasesTargeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitorSynthesis and biological evaluation of a novel class of curcumin analogs as anti-inflammatory agents for prevention and treatment of sepsis in mouse model.Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsJumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes.Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.HDACIs and the inhibition of invasive potential.The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway.
P2860
Q26866257-2B2BD031-12EA-4C95-9050-D3067AA96847Q27023599-7A4ED5E2-FE90-498E-8BBF-D6817E0B59F7Q33684732-E3784DC4-87DD-4AE5-8C11-2474574EABE1Q33909288-CDB5DB26-5052-4491-95CD-45E158ADAEF6Q34781159-BD442729-41C4-4B36-AC57-73D94A58DC31Q35209792-3B309A84-BBE2-4672-A1E4-BF0543C921F5Q36880907-3EFA64E2-C37D-4BFF-897E-9C24D195F2B3Q37594387-016E8F08-CE07-4683-95C5-9C86FD0575E3Q38308505-8836E360-9FF8-4186-9A6C-D551BAE8909EQ38993553-29E706AE-E732-4BAB-BE28-70BE2F314AA3Q41573533-FE530312-5F65-494C-97D5-5EC7BD32451EQ41863613-9C37D1FF-20BB-4AE3-B38F-1DBCD85E988CQ41905188-432D425E-83FD-4732-AE5D-F774DFDDD87CQ49571721-45AB881B-5DD7-43E9-B87D-34A8D41BF545Q53056147-2CADB5A4-5C58-4E3C-9D07-E9F69414EB19
P2860
HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
HO-3867, a STAT3 inhibitor ind ...... -mutated ovarian cancer cells.
@en
HO-3867, a STAT3 inhibitor ind ...... -mutated ovarian cancer cells.
@nl
type
label
HO-3867, a STAT3 inhibitor ind ...... -mutated ovarian cancer cells.
@en
HO-3867, a STAT3 inhibitor ind ...... -mutated ovarian cancer cells.
@nl
prefLabel
HO-3867, a STAT3 inhibitor ind ...... -mutated ovarian cancer cells.
@en
HO-3867, a STAT3 inhibitor ind ...... -mutated ovarian cancer cells.
@nl
P2093
P2860
P356
P1476
HO-3867, a STAT3 inhibitor ind ...... 1-mutated ovarian cancer cells
@en
P2093
Brent J Tierney
Eric Eisenhauer
Georgia A McCann
Karuppaiyah Selvendiran
Kálmán Hideg
Meryl Sudhakar
Periannan Kuppusamy
P2860
P304
P356
10.4161/CBT.20559
P577
2012-07-01T00:00:00Z